Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Trends in Molecular Medicine|January 13, 2006
LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?Julie P Taylor, Ignacio F Mata, Matt J FarrerTrends in Neurosciences|April 18, 2006
LRRK2 in Parkinson's disease: protein domains and functional insightsIgnacio F Mata, William J Wedemeyer, Matthew J Farrer, et al.The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
Mutations of the PDS gene, encoding pendrin, are associated with protein mislocalization and loss of iodide efflux: implications for thyroid dysfunction in Pendred syndromeJulie P Taylor, Russell A Metcalfe, Philip F Watson, et al.Annals of Neurology|May 31, 2023
Expert Panel Curation of 113 Primary Mitochondrial Disease Genes for the Leigh Syndrome SpectrumElizabeth M McCormick, Kierstin Keller, Julie P Taylor, et al.Cell Genomics|February 23, 2023
Reactive gene curation to support interpretation and reporting of a clinical genome test for rare disease: Experience from over 1,000 casesAmanda R Clause, Julie P Taylor, Revathi Rajkumar, et al.Neuroscience Letters|November 11, 2006
Digenic parkinsonism: investigation of the synergistic effects of PRKN and LRRK2Justus C Dächsel, Ignacio F Mata, Owen A Ross, et al.Neuroscience Letters|June 1, 2005
LRRK2 R1441G in Spanish patients with Parkinson's diseaseIgnacio F Mata, Julie P Taylor, Jennifer Kachergus, et al.Parkinsonism & Related Disorders|April 3, 2007
Identification of potential protein interactors of Lrrk2Justus C Dächsel, Julie P Taylor, Su San Mok, et al.Human Mutation|February 19, 2022
A clinical laboratory's experience using GeneMatcher-Building stronger gene-disease relationshipsJulie P Taylor, Alka Malhotra, Nicole J Burns, et al.Neurogenetics|September 21, 2005
Lrrk2 pathogenic substitutions in Parkinson's diseaseIgnacio F Mata, Jennifer M Kachergus, Julie P Taylor, et al.Pageof 2